Peptides in 2027: what is dated to change
Only changes an official source or a program has put a 2027 date on. Read November 19, 2026.
- The FDA says it will hold a Pharmacy Compounding Advisory Committee meeting before the end of February 2027 to discuss five substances for the 503A bulks list: cathelicidin (LL-37), GHK-Cu, dihexa acetate, Melanotan II and pegylated mechano growth factor (PEG-MGF). The date and place are not set. Source: FDA Pharmacy Compounding Advisory Committee meeting page (current as of April 15, 2026).
- The FDA's 503A category list says the agency intends to consult that committee about GHK-Cu before the end of February 2027, after putting GHK-Cu for routes other than injection back on Category 1. Source: FDA's 503A category lists (current as of May 14, 2026).